How is the C4 Therapeutics Inc today?

The C4 Therapeutics Inc today is trading in the green, up by 6.58% at 1.62.

How has C4 Therapeutics Inc performed historically?

The C4 Therapeutics Inc is currently trading up 6.58% on an intraday basis in the past week the index rose 5.19%. The index has been down -20.98% in the past quarter and fell -66.67% in the past year. You can view this in the overview section.

What is C4 Therapeutics Inc Annual Revenue?

C4 Therapeutics Inc Annual Revenue rose 71.44%, in the last year to $35.58 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is C4 Therapeutics Inc Annual Net Profit?

C4 Therapeutics Inc Annual Net Profit rose 20.51% in the last year to $105.32 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is C4 Therapeutics Inc Price to Earning Ratio?

C4 Therapeutics Inc Price to Earning Ratio is -1.11, which is negative.

What is C4 Therapeutics Inc Stock Price?

C4 Therapeutics Inc Stock Price fell 66.67% and underperformed its sector by 93.5% in the past year.

What is C4 Therapeutics Inc Quarterly Revenue?

C4 Therapeutics Inc Quarterly Revenue rose 138.17% YoY to $7.24 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is C4 Therapeutics Inc Quarterly Net profit?

C4 Therapeutics Inc Quarterly Net profit rose 7.19% YoY to $26.32 M. Its sector's average net profit growth YoY for the quarter was -238.58%.

What is C4 Therapeutics Inc Debt to Equity Ratio?

C4 Therapeutics Inc Debt to Equity Ratio of 0.3 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is C4 Therapeutics Inc Return on Equity(ROE)?

C4 Therapeutics Inc Return on Equity(ROE) for the last financial year was -45.58%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is C4 Therapeutics Inc Mutual Fund Holding?

C4 Therapeutics Inc Mutual Fund Holding decreased by 0.16% in the last quarter to 33.21.

What is C4 Therapeutics Inc Institutional Holding?

C4 Therapeutics Inc Institutional Holding decreased by 1.66% in the last quarter to 79.39.

C4 Therapeutics Inc XNAS: CCCC

C4 Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: C4 Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: C4 Therapeutics Inc
Rating: 1.354222125
Author: Trendlyne DVM scores

Momentum Trap

about

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targe...

1.62 0.10 (6.58%)

78.85% Fall from 52W High

1.2M

XNAS Volume

XNAS 12 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for C4 Therapeutics Inc is on 20 Jun 2025 for the purpose of C4 Therapeutics Inc Annual General Meeting for 2025 See details

Low Financial Strength

22.2 / 100

Expensive Valuation

25.3 / 100

Technically Neutral

38.6 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 749%

6 analysts

C4 Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

C4 Therapeutics Inc Live Share Price Today, Share Analysis and Chart

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targe...

78.85% Fall from 52W High

SWOT Analysis

C4 Therapeutics Inc Live Price Chart

C4 Therapeutics Inc FAQ

How is C4 Therapeutics Inc today?

C4 Therapeutics Inc today is trading in the green, and is up by 6.58% at 1.62.

How has C4 Therapeutics Inc performed historically?

C4 Therapeutics Inc is currently trading up 6.58% on an intraday basis. In the past week the stock rose 5.19%. stock has been down -20.98% in the past quarter and fell -66.67% in the past year. You can view this in the overview section.